Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesSitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations
Antimicrobial Agents and Chemotherapy, 06/25/09
Murakami K et al. - Sitafloxacin showed MICs of less than or equal to 0.5 µg/ml against 105 isolates of Helicobacter pylori, including 44 isolates with mutations in the gyrA gene. The highest MICs for garenoxacin and levofloxacin were 8 and 64 times, respectively, higher than the highest MICs observed for sitafloxacin.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Toll-like receptor 4 participates in gastric mucosal protection through Cox-2 and PGE2
Digestive and Liver Diseases, 12/18/09
Pdx-1 Regulation of the INGAP Promoter Involves Sequestration of NeuroD Into a Non-DNA-Binding Complex
Pancreas, 12/18/09
MDM2 SNP309 Associates With Accelerated Pancreatic Adenocarcinoma Formation
Pancreas, 12/18/09
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Test-and-treat strategy for Helicobacter pylori (HP) infection in older patients
Archives of Gerontology and Geriatrics, 12/18/09
Air cavitogram as investigative modality for Amoebic Liver Abscess
The Internet Journal of Gastroenterology, 12/18/09
Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after
BMC Infectious Diseases, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
New modalities and paradigms for sedation: new sedation agents
Techniques in Gastrointestinal Endoscopy , 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor